Elizabeth Acuna: The instructions and advice that I’ve been given regarding dupilumab, and the treatment schedule, have been really great. Obviously, it’s through the study protocol. So, I’ve been given some great advice about how to inject the medicine—following which areas to inject, which sites, and how to rotate that around. On top of that, calling in adverse reactions if I have anything. I make sure I call those in. The third thing is a weekly log, so I call in and report how I’m feeling. It’s a scale, 1-10, on certain things like how I’m feeling this week compared to other weeks. It really keeps a nice pulse on things. I definitely have some good follow-up and instructions where I feel very safe and very comfortable with the medication.
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Exploring Payer Coverage Decisions Following FDA Novel Drug Approvals
May 3rd 2022On this episode of Managed Care Cast, Ari D. Panzer, BS, lead author and researcher, then at Tufts Medical Center—now at Duke University—discusses the findings from his team’s investigation into coverage decisions by health plan insurers of the 66 drugs approved by the FDA in 2018.
Listen
2 Clarke Drive
Cranbury, NJ 08512